Cancer and transplantation intersect at the mammalian target of rapamycin.
MacDonald
Allan S
AS
Department of Surgery, Dalhousie University Halifax, Nova Scotia, Canada. allan.macdonald@dal.ca
D000818:Animals; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D009369:Neoplasms / Q000139:chemically induced / Q000201:enzymology* / Q000473:pathology; D016377:Organ Transplantation; D011494:Protein Kinases / Q000187:drug effects* / Q000378:metabolism; D020123:Sirolimus / Q000008:administration & dosage / Q000009:adverse effects*; D058570:TOR Serine-Threonine Kinases
D007166:Immunosuppressive Agents; D011494:Protein Kinases; C546842:MTOR protein, human; D058570:TOR Serine-Threonine Kinases; D020123:Sirolimus